Mirabella Financial Services LLP Intra Cellular Therapies, Inc. Transaction History

Mirabella Financial Services LLP

  • $1.11 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$64.76 - $79.84 $623,638 - $768,859
9,630 New
9,630 $659,000
Q1 2023

May 12, 2023
SELL
$43.8 - $56.99 $1.6 Million - $2.09 Million
-36,618 Reduced 85.39%
6,267 $339,000
Q4 2022

Feb 13, 2023
BUY
$44.07 - $54.45 $888,759 - $1.1 Million
20,167 Added 88.77%
42,885 $2.27 Million
Q3 2022

Oct 26, 2022
BUY
$42.7 - $59.99 $970,058 - $1.36 Million
22,718 New
22,718 $1.06 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email